![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 23681 |
FusionGeneSummary for NCOA3_SULF2 |
![]() |
Fusion gene information | Fusion gene name: NCOA3_SULF2 | Fusion gene ID: 23681 | Hgene | Tgene | Gene symbol | NCOA3 | SULF2 | Gene ID | 8202 | 55959 |
Gene name | nuclear receptor coactivator 3 | sulfatase 2 | |
Synonyms | ACTR|AIB-1|AIB1|CAGH16|CTG26|KAT13B|RAC3|SRC-3|SRC3|TNRC14|TNRC16|TRAM-1|bHLHe42|pCIP | HSULF-2 | |
Cytomap | 20q13.12 | 20q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear receptor coactivator 3CBP-interacting proteinamplified in breast cancer 1 proteinclass E basic helix-loop-helix protein 42receptor-associated coactivator 3steroid receptor coactivator protein 3thyroid hormone receptor activator molecule 1 | extracellular sulfatase Sulf-2 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q9Y6Q9 | Q8IWU5 | |
Ensembl transtripts involved in fusion gene | ENST00000341724, ENST00000372004, ENST00000371998, ENST00000371997, ENST00000497292, | ENST00000359930, ENST00000484875, ENST00000361612, ENST00000467815, ENST00000478766, | |
Fusion gene scores | * DoF score | 17 X 8 X 9=1224 | 3 X 3 X 4=36 |
# samples | 21 | 4 | |
** MAII score | log2(21/1224*10)=-2.54314232502653 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: NCOA3 [Title/Abstract] AND SULF2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NCOA3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 9267036 |
Hgene | NCOA3 | GO:0071392 | cellular response to estradiol stimulus | 15831516 |
Tgene | SULF2 | GO:0030177 | positive regulation of Wnt signaling pathway | 19520866 |
Tgene | SULF2 | GO:0030201 | heparan sulfate proteoglycan metabolic process | 18687675 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | UCS | TCGA-N6-A4VE-01A | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000341724 | ENST00000359930 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000341724 | ENST00000484875 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000341724 | ENST00000361612 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000341724 | ENST00000467815 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
5CDS-intron | ENST00000341724 | ENST00000478766 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000372004 | ENST00000359930 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000372004 | ENST00000484875 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000372004 | ENST00000361612 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000372004 | ENST00000467815 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
5CDS-intron | ENST00000372004 | ENST00000478766 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371998 | ENST00000359930 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371998 | ENST00000484875 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371998 | ENST00000361612 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371998 | ENST00000467815 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
5CDS-intron | ENST00000371998 | ENST00000478766 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371997 | ENST00000359930 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371997 | ENST00000484875 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371997 | ENST00000361612 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Frame-shift | ENST00000371997 | ENST00000467815 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
5CDS-intron | ENST00000371997 | ENST00000478766 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
intron-3CDS | ENST00000497292 | ENST00000359930 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
intron-3CDS | ENST00000497292 | ENST00000484875 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
intron-3CDS | ENST00000497292 | ENST00000361612 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
intron-3CDS | ENST00000497292 | ENST00000467815 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
intron-intron | ENST00000497292 | ENST00000478766 | NCOA3 | chr20 | 46276110 | + | SULF2 | chr20 | 46331414 | - |
Top |
FusionProtFeatures for NCOA3_SULF2 |
![]() |
Hgene | Tgene |
NCOA3 | SULF2 |
Exhibits arylsulfatase activity and highly specificendoglucosamine-6-sulfatase activity. It can remove sulfate fromthe C-6 position of glucosamine within specific subregions ofintact heparin. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NCOA3_SULF2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NCOA3_SULF2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NCOA3 | AR, BRCA1, EP300, ANKRD11, NPAS2, NR3C1, YWHAQ, PRMT1, NR4A1, NR2F1, RXRA, CCND1, ESRRA, ESRRB, NKX2-1, CREBBP, ESR1, ESR2, NR0B2, NR5A2, NCOA2, TRIM21, IKBKG, IKBKB, CHUK, VDR, PGR, HIST3H3, HIST4H4, CARM1, ABL1, FOS, NCOR1, ETS1, ETS2, PPARG, NCOA1, THRA, STAT6, SMAD2, SMAD3, ATAD2, KAT2B, RARA, NCOR2, SPOP, CDKN3, IQCK, BRE, DCTN6, CSNK1E, RARG, NR1H3, NR1H2, THRB, SPTA1, MYH9, ACTA1, ANXA2, TPR, MORC2, NFATC3, PSME3, EIF3E, CUL3, NFKB1, MAPK14, MAPK1, MAPK8, GSK3B, RFX1, TP53BP1, PSMC5, PRKCZ, TFF1, PSMA3, MYOCD, CEBPA, CEBPD, UBE3A, E2F1, PIN1, ELAVL1, TP53, KANK2, NR1I2, ALB, MMS19, PTEN, FBXW7, ARNT2, PSMB9, ETV1, PPARD, PPARA, NR1I3, MN1, MKL1, MKL2, HNF1A, RELA, EWSR1, XPO1, XRCC5, TMEM132A, PIAS1, RAB28, FOXA1 | SULF2 | MYC, PTCH1, CASQ2, NAAA, PON2, CSGALNACT2, APP, LRRC4C, DEFA1, GPR156, OS9, KBTBD7, SDC2, DKK3, DEFA5, TRPC4AP, GNS |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NCOA3_SULF2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NCOA3_SULF2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NCOA3 | C0023418 | leukemia | 2 | CTD_human |
Hgene | NCOA3 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Hgene | NCOA3 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | NCOA3 | C0004114 | Astrocytoma | 1 | CTD_human |
Hgene | NCOA3 | C0005967 | Bone neoplasms | 1 | CTD_human |
Hgene | NCOA3 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | NCOA3 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | NCOA3 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | SULF2 | C0014175 | Endometriosis | 2 | CTD_human |